Regeneron beats quarterly estimates on eczema drug demand; launches dividend program - Reuters

Reuters | Feb. 4, 2025, 8:15 a.m. | Original
Regeneron beats quarterly estimates on eczema drug demand; launches dividend program Reuters
Fox Corp quarterly results beat estimates on higher political ad spending - Reuters Australia bans DeepSeek on government devices citing security concerns - Reuters